Corus Pharma Alternatives & Competitors
12 companies similar to Corus Pharma — Driving advancements in respiratory health with innovative inhalable treatments.
Companies similar to Corus Pharma
Curza
Small molecule therapeutics R&D company focused on developing new drugs to combat antibiot...
ProQR Therapeutics
Advancing our proprietary Axiomer™ RNA-editing platform technology
Lumobiotics GmbH
Startup developing anti-cancer & anti-microbial photocontrollable peptidomimetics.
Rival Readout
Competing with Corus Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
AM-Pharma
AM-Pharma’s ilofotase alfa is being developed as potential enzyme replacement therapy for...
Alchemab Therapeutics Ltd
Pioneering Patient-led Antibody Therapeutics
RIGImmune Inc.
Targeted non-LNP Delivery of RNA Therapeutics
Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver dise...
Melinta Therapeutics
Unparalleled in Passion & Purpose
Savara Inc.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases....
ObsEva SA
ObsEva. Nature meets Nurture
Chinook Therapeutics, a Novartis Company
Changing the Course of Kidney Care
About Corus Pharma
Corus Pharma is a U.S.-based biotech and specialty drug company founded in 2001. The company focuses on advancing respiratory and infectious disease treatments through innovative inhalable therapies. Their product portfolio includes Corus 1020, an inhalable form of the antibiotic aztreonam for respiratory infections in...
Biotech, Specialty Drugs, Respiratory Health, Inhalable Treatments, Cystic Fibrosis, Antibiotics, Infectious Diseases, Biopharmaceutical, Drug Development, Therapeutics, Acquisition, Gilead Sciences, Innovative Treatments, Lidocaine, Asthma
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Corus Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Corus Pharma on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.